Medicare Part D drug Data year 2024 Brand name Source: CMS Part D Prescribers

Skyrizi

Risankizumab-Rzaa

Open in the dashboard

Part D claims

2,782

Prescriptions dispensed, refills included

Drug cost

$54,434,534

Paid at the pharmacy, in all

Prescribers

165

With 11 or more claims of it

In 2024, Medicare Part D recorded 2,782 claims for Skyrizi (risankizumab-rzaa) from 165 prescribers, at a total drug cost of $54.4 million paid at the pharmacy by Medicare, patients and others.

Where it is prescribed

By the prescriber's state · 38 states and territories
Part D claims for Skyrizi by the state of the prescriber, 2024
State Relative to the most Prescribers Claims Drug cost
NY 27 508 $10,196,654
CA 11 199 $4,025,772
PA 8 163 $3,313,423
TX 7 143 $2,814,412
OH 10 138 $2,587,805
FL 9 130 $2,071,191
MA 7 120 $2,323,535
MI 7 108 $2,134,546
MS 5 106 $1,914,794
NJ 5 102 $2,043,659
CT 5 98 $2,058,418
GA 6 85 $1,783,920
SC 6 85 $1,581,639
NC 5 81 $1,730,130
AL 5 70 $1,150,311
The other 23 states and territories
State Prescribers Claims Drug cost
MD 4 68 $1,470,774
MO 4 63 $1,414,318
KY 4 59 $1,209,960
IL 4 53 $1,057,716
WV 2 47 $969,653
NV 2 41 $855,209
IN 3 38 $785,723
WI 1 36 $737,092
RI 3 35 $578,044
OR 2 23 $428,495
PR 1 20 $459,251
WA 1 19 $215,858
AZ 1 16 $158,935
KS 1 15 $147,463
UT 1 15 $303,961
ID 1 14 $142,091
OK 1 13 $368,014
CO 1 13 $264,605
LA 1 12 $120,416
TN 1 12 $259,168
NH 1 12 $243,855
ME 1 11 $248,192
HI 1 11 $265,533

The state is where the prescriber practices, not where the patient lives. Totals are Medicare Part D claims only.

Which specialties prescribe it

Top 6 of 6
Part D claims for Skyrizi by prescriber specialty, 2024
Specialty Relative to the most Prescribers Claims Drug cost
Dermatology 87 1,552 $31,655,299
Physician Assistant 38 612 $12,142,236
Nurse Practitioner 24 402 $7,518,817
Gastroenterology 11 139 $1,418,673
Rheumatology 4 60 $1,365,272
Family Practice 1 17 $334,238

Specialty is the one printed on each prescriber's Medicare claims.

Largest prescribers

First 5 of 100 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Huachen Wei Dermatology NY 48 $955,645 $11,823
Ashlynn Bennett Nurse Practitioner MS 41 $794,655 $284
Jerry Bagel Dermatology NJ 39 $809,713 $46,440
Jun Lu Dermatology CT 37 $792,253 None on record
Mychael Luu Dermatology CA 37 $760,488 $396

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 100 with Patron

Industry payments naming this drug

From CMS Open Payments

Open Payments names products as manufacturers reported them, and CMS does not link them to Part D drugs, so this match is by name and ours. The two records are separate: they do not show that a payment affected a prescription.

Other names for risankizumab-rzaa

What this means

Medicare Part D is the part of Medicare that covers prescription drugs dispensed at a pharmacy. Each year CMS publishes, for every prescriber and drug, how many claims were dispensed and what they cost. This page adds those up for one drug.

A claim is one prescription filled, refills included. Drug cost is the total paid at the pharmacy by Medicare, the patient and anyone else; it is not money to the prescriber. CMS leaves out any prescriber with fewer than 11 claims of a drug, so the prescriber count is a floor and a missing prescriber does not mean none.

Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy. It does not include drugs given in a clinic or hospital, patients with other insurance, or the most recent year, which Medicare publishes about two years behind.

Provenance

Source: CMS Medicare Part D Prescribers by Provider and Drug · data year 2024

We reproduce what CMS published. We do not verify, edit or correct the underlying records.

A prescription record is not evidence of wrongdoing, and nothing here is medical advice. Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency.

How to dispute or correct a record